Schellens JH - Search Results

1

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours.

de Jonge M, de Weger VA, Dickson MA, Langenberg M, Le Cesne A, Wagner AJ, Hsu K, Zheng W, Macé S, Tuffal G, Thomas K, Schellens JH. de Jonge M, et al. Among authors: schellens jh. Eur J Cancer. 2017 May;76:144-151. doi: 10.1016/j.ejca.2017.02.005. Epub 2017 Mar 17. Eur J Cancer. 2017. PMID: 28324749 Clinical Trial.

2

A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.

Planting A, Kho S, van der Burg M, Goey H, Schellens J, van den Bent M, van der Gaast A, de Boer-Dennert M, Stoter G, Verweij J. Planting A, et al. Cancer Chemother Pharmacol. 1997;40(4):347-52. doi: 10.1007/s002800050668. Cancer Chemother Pharmacol. 1997. PMID: 9225954 Free article. Clinical Trial.

3

The combined use of radiotherapy and chemotherapy in the treatment of solid tumours.

Bartelink H, Schellens JH, Verheij M. Bartelink H, et al. Among authors: schellens jh. Eur J Cancer. 2002 Jan;38(2):216-22. doi: 10.1016/s0959-8049(01)00363-x. Eur J Cancer. 2002. PMID: 11803138 Review.

4

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours.

Crul M, Rosing H, de Klerk GJ, Dubbelman R, Traiser M, Reichert S, Knebel NG, Schellens JH, Beijnen JH, ten Bokkel Huinink WW. Crul M, et al. Among authors: schellens jh. Eur J Cancer. 2002 Aug;38(12):1615-21. doi: 10.1016/s0959-8049(02)00127-2. Eur J Cancer. 2002. PMID: 12142051 Clinical Trial.

5

A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin.

Schoemaker NE, van Kesteren C, Rosing H, Jansen S, Swart M, Lieverst J, Fraier D, Breda M, Pellizzoni C, Spinelli R, Grazia Porro M, Beijnen JH, Schellens JH, ten Bokkel Huinink WW. Schoemaker NE, et al. Among authors: schellens jh. Br J Cancer. 2002 Sep 9;87(6):608-14. doi: 10.1038/sj.bjc.6600516. Br J Cancer. 2002. PMID: 12237769 Free PMC article. Clinical Trial.

6

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer.

Schellens JH, Planting AS, van Zandwijk N, Ma J, Maliepaard M, van der Burg ME, de Boer-Dennert M, Brouwer E, van der Gaast A, van den Bent MJ, Verweij J. Schellens JH, et al. Br J Cancer. 2003 Mar 24;88(6):814-21. doi: 10.1038/sj.bjc.6600794. Br J Cancer. 2003. PMID: 12644815 Free PMC article. Clinical Trial.

7

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG).

Terret C, Zanetta S, Roché H, Schellens JH, Faber MN, Wanders J, Ravic M, Droz JP; EORTC Early Clinical Study Group. Terret C, et al. Among authors: schellens jh. Eur J Cancer. 2003 May;39(8):1097-104. doi: 10.1016/s0959-8049(03)00128-x. Eur J Cancer. 2003. PMID: 12736109 Clinical Trial.

8

Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).

Chollet P, Schöffski P, Weigang-Köhler K, Schellens JH, Cure H, Pavlidis N, Grünwald V, De Boer R, Wanders J, Fumoleau P; EORTC Early Clinical Studies Group. Chollet P, et al. Among authors: schellens jh. Eur J Cancer. 2003 Jun;39(9):1264-70. doi: 10.1016/s0959-8049(03)00237-5. Eur J Cancer. 2003. PMID: 12763215 Clinical Trial.

9

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks.

Kerbusch T, Groenewegen G, Mathôt RA, Herben VM, ten Bokkel Huinink WW, Swart M, Ambaum B, Rosing H, Jansen S, Voest EE, Beijnen JH, Schellens JH. Kerbusch T, et al. Among authors: schellens jh. Br J Cancer. 2004 Jun 14;90(12):2268-77. doi: 10.1038/sj.bjc.6601861. Br J Cancer. 2004. PMID: 15150579 Free PMC article. Clinical Trial.

10

A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.

Rademaker-Lakhai JM, Terret C, Howell SB, Baud CM, De Boer RF, Pluim D, Beijnen JH, Schellens JH, Droz JP. Rademaker-Lakhai JM, et al. Among authors: schellens jh. Clin Cancer Res. 2004 May 15;10(10):3386-95. doi: 10.1158/1078-0432.CCR-03-0315. Clin Cancer Res. 2004. PMID: 15161693 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

891 results

Search Page

Filters